Filing Details
- Accession Number:
- 0001209191-17-048081
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-08 16:04:18
- Reporting Period:
- 2017-08-04
- Filing Date:
- 2017-08-08
- Accepted Time:
- 2017-08-08 16:04:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1488613 | Foundation Medicine Inc. | FMI | Services-Medical Laboratories (8071) | 271316416 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585001 | Krishna Yeshwant | C/O Foundation Medicine, Inc. 150 Second Street Cambridge MA 02141 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-04 | 18,072 | $36.85 | 5,786 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-08-04 | 13,385 | $24.21 | 19,171 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-04 | 8,585 | $37.75 | 10,586 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock | Disposition | 2017-08-04 | 13,385 | $0.00 | 13,385 | $24.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-06-18 | 2024-06-18 | No | 4 | M | Direct |
Footnotes
- The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.70 to $36.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Billionaire Hedge Funds
